Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-19

FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for ziprasidone hydrochloride from Apotex Corp., enabling the marketing of a generic version of the antipsychotic. This …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZIPRASIDONE HYDROCHLORIDE (Ziprasidone hydrochloride)

Snippet

SUPPL AP for ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE HCL)